Skip to Main Content

Paper Details

BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.
Nat Cell Biol
43
2022
Author NameAffiliation
Avi J SamelsonInstitute for Neurodegenerative Diseases, University of California San Francisco
Avi J Samelson
R??my RobinotInstitut Pasteur, Universite de Paris
Veronica V RezeljInstitut Pasteur
Irene LuiDepartment of Pharmaceutical Chemistry, University of California San Francisco
Jared Carlson-StevermerSynthego Corporation
Jennifer OkiSynthego Corporation
Travis J MauresSynthego Corporation
Kevin HoldenSynthego Corporation
Jonathan S WeissmanUniversity of California San Francisco
Jonathan S WeissmanHoward Hughes Medical Institute, University of California San Francisco
Jonathan S WeissmanWhitehead Institute for Biomedical Research
Jonathan S WeissmanMassachusetts Institute of Technology
James A Wells
James A WellsDepartment of Pharmaceutical Chemistry, University of California San Francisco
James A WellsUniversity of California San Francisco
Bruce R ConklinGladstone Institutes
Bruce R ConklinUniversity of California San Francisco
Bruce R ConklinUniversity of California San Francisco
Bruce R ConklinUniversity of California San Francisco
Benjamin R tenOever
Marco VignuzziInstitut Pasteur
Martin KampmannInstitute for Neurodegenerative Diseases, University of California San Francisco
Martin Kampmann
Martin KampmannUniversity of California San Francisco
  • 1 - 25

Datasets

Release 1.2